HAVCR2 and cancer: In addition, overexpression of TIM-3 predicts poor outcome in multiple cancer types and anti-TIM-3 was shown to reduce suppression on IFN-γ-producing CD8+ T cells (Fourcade et al., 2010; Lu et al., 2017b; Shayan et al., 2017).